Latest Reimbursement News

IperionX has transitioned its Virginia titanium operations to continuous 24/7 production, ramping proprietary HAMR™ titanium powder output to 4.2 metric tons in March and targeting 200 tons per annum by the end of 2026. Alongside manufacturing capacity expansions and strong U.S. Department of War backing, the company advances its critical minerals project in Tennessee.

Imricor Medical Systems updates its SEC Form 10 with minor SEC-driven revisions as it pushes forward with FDA clearances and clinical trials, reporting a $25.3 million net loss in 2025 amid early-stage commercialisation.

Diatreme Resources reported a $745,000 net loss for FY 2025 but strengthened its financial footing through asset sales and an IPO stake. The company’s Northern Silica Project and Cyclone Zircon Project showed significant technical progress, while a major Cape Flattery asset sale aims to streamline operations and unlock funding.

Macallum New Energy has successfully listed on the ASX and raised A$7.4 million to fund exploration in the Northern Perth Basin. The company is progressing a 66% complete Barberton 3D seismic survey and preparing a Condor 2D survey, positioning itself amid renewed regional drilling activity.

EBR Systems secures Priority Review from Australia's TGA for its wireless cardiac pacing system, fast-tracking regulatory approval and expanding access for heart failure patients. This follows strong US commercial momentum after FDA approval.

Phoslock Environmental Technologies reported a stable sales volume and improved cash flow compared to last year, while ramping up production after reopening its Chinese factory. The company is advancing R&D on a new lanthanum product and faces ongoing legal challenges with mediation set for June.

BCAL Diagnostics has expanded its Avantect cancer blood tests nationally through major pathology networks, generating $88,000 in Q3 revenue from 91 tests. The company also submitted an initial Medicare reimbursement application for pancreatic cancer detection and is preparing to launch an enhanced BREASTESTplus 2.0 test in early 2027.

Critica Limited has produced its first commercial-quality Mixed Rare Earth Carbonate at 58% TREO, confirming a refinery-aligned product pathway, while launching a major resource upgrade drilling program at its Jupiter Rare Earths Project in Western Australia.

Galileo Mining maintains a strong cash position of approximately A$8.2 million as it confirms extensive PGE-nickel-copper mineralisation at Norseman's Mission Sill and completes deep diamond drilling beneath the Callisto deposit.

Lindian Resources has locked in a US$11.6 million financing package from Malawi's NBS Bank, bolstering the Kangankunde Rare Earths Project with asset-backed and working capital facilities. This deal complements Lindian’s recent A$100 million placement and underscores its commitment to local partnerships.

4DMedical lands a contract with pharma giant GSK, gains UKCA certification for its CT:VQ™ lung imaging technology, and joins the S&P/ASX 200, marking a significant step in its global expansion.

Emyria has unveiled the Empax Global Partnership Program, a high-margin clinical delivery platform targeting international drug sponsors amid growing demand for psychedelic-assisted mental health treatments.